Loading...
•
Mar 31, 2022
Vericel Q1 2022 Earnings Report
Vericel reported financial results for the first quarter ended March 31, 2022.
Key Takeaways
Vericel Corporation reported a 4% increase in total net revenue for Q1 2022, reaching $36.1 million compared to $34.6 million in Q1 2021. The company experienced a net loss of $7.1 million, or $0.15 per share, compared to a net loss of $3.3 million, or $0.07 per share, in the same quarter of the previous year.
Total net revenue reached $36.1 million, a 4% increase compared to Q1 2021.
MACI net revenue was $26.0 million, while Epicel net revenue was $9.9 million.
Net loss amounted to $7.1 million, or $0.15 per share.
The company had approximately $130 million in cash, restricted cash and investments as of March 31, 2022.
Revenue by Segment
Forward Guidance
The Company reaffirmed financial guidance for full-year 2022
Positive Outlook
- Total net revenue for 2022 expected to be in the range of $178 to $189 million
- MACI revenue expected to be in the range of $132 to $141 million
- Epicel revenue expected to be in the range of $45.5 to $47.5 million
- Gross margin expected to be approximately 70%
- Adjusted EBITDA margin expected to be approximately 21%
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...